Investing Investment Strategy


  • Short Covering Rally or Something More?

    The FMHR traders discuss what's behind the market rally. Tony Crescenzi, portfolio manager at PIMCO also discusses Fed Chairman Bernanke's next move.

  • Cashin's Take on 'Snapback Rally'

    Art Cashin, UBS director of floor operations, provides insight on what's behind the surge in stocks.

  • Money In Motion: 'Relief Rally' for Euro?

    "The fact that that the ECB left rates on hold and the euro has held up here, it leads me to believe that we'll get a nice relief rally," says Andrew Busch, BMO Capital Markets.

  • Tempur-Pedic Cloud Luxe

    Now we know why Tempur-Pedic’s stock has been unusually weak and downright horrible for the past month: The usual Memorial Day mattress sales didn’t bounce its way.

  • chinese-investors_200.jpg

    Trading in the Chinese market is likely to remain cautious ahead of key May industrial production data due for release on Saturday.

  • bubble_burst.jpg

    I’ve seen my share of controversial companies, but Ubiquiti Networks is one for the books, writes CNBC's Herb Greenberg.

  • market-insider-stocks-to-watch-200.jpg

    Take a look at some of Wednesday’s morning movers:

  • Gold

    The Market Vectors Gold Miners Index exchange-traded fund drew some bullish option activity yesterday as traders focus increasingly on precious metals.

  • businessmen-boxing-blue-red-gloves200.jpg

    Traders are handicapping which central bank will come out swinging first — and the odds right now are not on the European Central Bank.

  • Wisconsin Recall Roundup

    CNBC's John Harwood reports an update from the Wisconsin recall; and breaking down the fight between the Tea Party and taxpayers versus government unions, with Representative Sean Duffy (R-WI) and Senator Chris Larson (D-WI). "Unions are what created the middle class and the middle class is what has made America strong," says Duffy.

  • Seattle Genetics CEO on ADCETRIS Drug For Hodgkins

    Clay Siegall, Seattle Genetics president & CEO, discusses his company's latest drug developments for non-hodgkins lymphoma and hodgkins lymphoma, and its opportunity to be a "$1 billion plus product on its own."

  • Lightning Round

    You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

  • Short & Long Term Market Outlook

    Mad Money host Jim Cramer explains why investors could be a bit more bullish, so long as the S&P 500 can remain above 1250.

  • Facebook: A Friend or Foe?

    Mad Money host Jim Cramer reveals financial institutions' strategy around Facebook's IPO mess, and weighs in on the company's recent fallout.

  • Fast Money Web Extra

    The Fast Money crew offers special advice on your investments.

  • Markets: Worst Case, Best Case?

    Mad Money host Jim Cramer breaks down the best and worst case scenarios for the market; and explains why a compromise between Spain and Germany is necessary right now, and if Europe were to stabilize, stocks could soar.

  • Trading Stocks: There's An App For That

    Ditto Trade founder and CEO Joe Fox, just unveiled a new app that lets users trade stocks like the professionals by using a social platform.

  • Fast Money Portfolio: Treasure Stocks Amid Europe's Turmoil?

    Thomas Russo, Gardner, Russo & Gardner partner, discusses how long-term investing can meet the volatility in today's economy.

  • Dividend Stocks About to Pay Out

    The Fast Money traders share their top dividend stock picks, including UNS Energy Corp, Merck and Altria.

  • Bargain Buys in Industrials

    According to the WSJ, the Nasdaq plans to begin compensating investors for Facebook's botched IPO; and breaking down the plays in the industrial sector, even though its down 8% over the past month, with the Fast Money traders and Jeff Sprague, Vertical Research Partners.